Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B ... five times more potent than selegiline.

Coadministration of rasagiline and ciprofloxacin (a CYP1A2 inhibitor) increases the AUC ... However, based on wide clinical experience with selegiline, the risk of hypertensive crisis associated ...

Q: My brother is approaching 81 and is having difficulties with his memory. His doctor has prescribed donepezil. As far as I can tell, investigation on drugs that help with dementia and Alzheimer’s is ...

When used in everyday practice, sodium-glucose cotransporter 2 (SGLT2) inhibitors provide rapid and sustained benefits to patients with a recent heart failure (HF) hospitalization, a nationwide ...

You should not use other medications with dextromethorphan, including Robitussin and Mucinex DM, if you have taken a monoamine oxidase inhibitor (MAOI) within the past two weeks. There are no ...

Final results from the Phase III MYR301 trial show that extended treatment with bulevirtide—Gilead’s entry inhibitor for chronic hepatitis delta virus (HDV)—may lead to durable virologic suppression ...

selective inhibitor. Avenzo has also exercised its exclusive option for AVZO-023 from Allorion Therapeutics Inc., securing global (excluding Greater China) development, manufacturing, and ...

You shouldn’t take this medication if you’re taking a monoamine oxidase inhibitor, if you have heart disease, or if you’ve had a bad reaction to another stimulant drug. One of the more ...

Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab ...